Cargando…
Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer
The locus at 17q12 erb‐b2 receptor tyrosine kinase 2 (ERBB2) has been heavily amplificated and overexpressed in gastric cancer (GC), but it remains to be elucidated about the clinical significance of the co‐amplification and co‐overexpression of PGAP3 gene located around ERBB2 in GC. The profile of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424286/ https://www.ncbi.nlm.nih.gov/pubmed/37386793 http://dx.doi.org/10.1111/jcmm.17828 |
_version_ | 1785089641008857088 |
---|---|
author | Wang, Dong Hao, Siyu He, Hongjie Zhang, Jian You, Ge Wu, Xin Zhang, Rui Meng, Xiangning Cui, Xiaobo Bai, Jing Fu, Songbin Yu, Jingcui |
author_facet | Wang, Dong Hao, Siyu He, Hongjie Zhang, Jian You, Ge Wu, Xin Zhang, Rui Meng, Xiangning Cui, Xiaobo Bai, Jing Fu, Songbin Yu, Jingcui |
author_sort | Wang, Dong |
collection | PubMed |
description | The locus at 17q12 erb‐b2 receptor tyrosine kinase 2 (ERBB2) has been heavily amplificated and overexpressed in gastric cancer (GC), but it remains to be elucidated about the clinical significance of the co‐amplification and co‐overexpression of PGAP3 gene located around ERBB2 in GC. The profile of PGAP3 and ERBB2 in four GC cell lines and tissue microarrays containing 418 primary GC tissues was assessed to investigate the co‐overexpression and clinical significance of the co‐amplified genes, and to evaluate the impact of the co‐amplified genes on the malignancy of GC. Co‐amplification of PGAP3 and ERBB2 accompanied with co‐overexpression was observed in a haploid chromosome 17 of NCI‐N87 cells with double minutes (DMs). PGAP3 and ERBB2 were overexpressed and positively correlated in 418 GC patients. Co‐overexpression of the PGAP3 and ERBB2 was correlated with T stage, TNM stage, tumour size, intestinal histological type and poor survival proportion in 141 GC patients. In vitro, knockdown of the endogenous PGAP3 or ERBB2 decreased cell proliferation and invasion, increased G1 phase accumulation and induced apoptosis in NCI‐N87 cells. Furthermore, combined silencing of PGAP3 and ERBB2 showed an additive effect on resisting proliferation of NCI‐N87 cells compared with targeting ERBB2 or PGAP3 alone. Taken together, the co‐overexpression of PGAP3 and ERBB2 may be crucial due to its significant correlation with clinicopathological factors of GC. Haploid gain of PGAP3 co‐amplified with ERBB2 is sufficient to facilitate the malignancy and progression of GC cells in a synergistic way. |
format | Online Article Text |
id | pubmed-10424286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104242862023-08-15 Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer Wang, Dong Hao, Siyu He, Hongjie Zhang, Jian You, Ge Wu, Xin Zhang, Rui Meng, Xiangning Cui, Xiaobo Bai, Jing Fu, Songbin Yu, Jingcui J Cell Mol Med Original Articles The locus at 17q12 erb‐b2 receptor tyrosine kinase 2 (ERBB2) has been heavily amplificated and overexpressed in gastric cancer (GC), but it remains to be elucidated about the clinical significance of the co‐amplification and co‐overexpression of PGAP3 gene located around ERBB2 in GC. The profile of PGAP3 and ERBB2 in four GC cell lines and tissue microarrays containing 418 primary GC tissues was assessed to investigate the co‐overexpression and clinical significance of the co‐amplified genes, and to evaluate the impact of the co‐amplified genes on the malignancy of GC. Co‐amplification of PGAP3 and ERBB2 accompanied with co‐overexpression was observed in a haploid chromosome 17 of NCI‐N87 cells with double minutes (DMs). PGAP3 and ERBB2 were overexpressed and positively correlated in 418 GC patients. Co‐overexpression of the PGAP3 and ERBB2 was correlated with T stage, TNM stage, tumour size, intestinal histological type and poor survival proportion in 141 GC patients. In vitro, knockdown of the endogenous PGAP3 or ERBB2 decreased cell proliferation and invasion, increased G1 phase accumulation and induced apoptosis in NCI‐N87 cells. Furthermore, combined silencing of PGAP3 and ERBB2 showed an additive effect on resisting proliferation of NCI‐N87 cells compared with targeting ERBB2 or PGAP3 alone. Taken together, the co‐overexpression of PGAP3 and ERBB2 may be crucial due to its significant correlation with clinicopathological factors of GC. Haploid gain of PGAP3 co‐amplified with ERBB2 is sufficient to facilitate the malignancy and progression of GC cells in a synergistic way. John Wiley and Sons Inc. 2023-06-29 /pmc/articles/PMC10424286/ /pubmed/37386793 http://dx.doi.org/10.1111/jcmm.17828 Text en © 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Wang, Dong Hao, Siyu He, Hongjie Zhang, Jian You, Ge Wu, Xin Zhang, Rui Meng, Xiangning Cui, Xiaobo Bai, Jing Fu, Songbin Yu, Jingcui Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer |
title | Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer |
title_full | Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer |
title_fullStr | Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer |
title_full_unstemmed | Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer |
title_short | Contribution of PGAP3 co‐amplified and co‐overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer |
title_sort | contribution of pgap3 co‐amplified and co‐overexpressed with erbb2 at 17q12 involved poor prognosis in gastric cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424286/ https://www.ncbi.nlm.nih.gov/pubmed/37386793 http://dx.doi.org/10.1111/jcmm.17828 |
work_keys_str_mv | AT wangdong contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT haosiyu contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT hehongjie contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT zhangjian contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT youge contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT wuxin contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT zhangrui contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT mengxiangning contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT cuixiaobo contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT baijing contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT fusongbin contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer AT yujingcui contributionofpgap3coamplifiedandcooverexpressedwitherbb2at17q12involvedpoorprognosisingastriccancer |